Providing Free Drug Will Not Trigger Sanctions, HHS OIG Says

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

By signing up for a tour of the Thompson FDA Compliance Expert Suite, you are also registering to receive email offers and product updates from us. Simply click unsubscribe at the bottom of any email if you would like to discontinue delivery.

Providing Free Drug That Has Only Limited Coverage Will Not Trigger Sanctions, HHS OIG Says

Dennis Tosh

January 22, 2025 at 03:49 PM EST

In a Jan. 10 advisory opinion, the Department of Health and Human Services (HHS) Office of Inspector General (OIG) determined that a pharmaceutical company program providing some patients with free access to a drug that has limited federal health care program coverage would not trigger the imposition of administrative sanctions under federal statutes targeting health care frau... Read More

My Research Folders

You are not Logged in yet, Please login to see Your research folders.

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

Providing Free Drug That Has Only Limited Coverage Will Not Trigger Sanctions, HHS OIG Says

My Research Folders

THOMPSON FDA

COMPLIANCE EXPERT

RESOURCES

HELP

CONTACT